LILONGWE, Malawi -- The Abbott Fund, Baylor College of Medicine and the government of Malawi have announced they will partner in the establishment of Malawis first center dedicated to providing care and treatment for children with HIV/AIDS. Construction of the new clinic on the Kamuzu Central Hospital campus in Lilongwe is to begin in April and should be completed by December 2005. The Malawi clinic is the latest addition to the rapidly growing Baylor pediatric network, which forms the largest group of clinics devoted to treating children with HIV/AIDS in the developing world.
Due to the overwhelming impact of the AIDS pandemic, the complexity of treating HIV-infected children, and a lack of resources and specialized training, there has been little focus on pediatric HIV treatment in developing countries like Malawi. The new pediatric center, which will be staffed collaboratively by Baylor and local health professionals, is designed to help address this unmet need through a comprehensive approach to pediatric treatment and care.
The clinic is being funded by a three-year, $1.5 million grant for construction and ongoing operations from the Abbott Funds Step Forward program, which to date has provided more than $12 million in grants and donated product to Baylor initiatives aimed at advancing programs, knowledge and health professional training to address pediatric HIV/AIDS in the developing world.
The Malawi center will be modeled after the Romanian-American Childrens Center, the first stand-alone pediatric AIDS clinic in the developing world. Through an innovative approach to treatment at this pediatric center supported by the Abbott Fund, children are provided with state-of-the-art medical treatment, including antiretroviral therapy. A comprehensive program of support also is provided for children and their families, including psychosocial counseling, support groups, and awareness and prevention education. This model program has reduced pediatric AIDS mortality by more than 90 percent in four years in Constanta, Romania, the epicenter of pediatric HIV in Eastern Europe.
Abbott Fund and Baylor have pioneered a model in Romania that is now being successfully replicated throughout the developing world and will be instrumental to scaling up treatment and care for children with HIV, said Mark W. Kline, MD, director, Baylor International Pediatric AIDS Initiative, Baylor College of Medicine. With the commitment of the Government of Malawi, were hoping to achieve similar results, and transform the delivery of care for children with HIV in Malawi.
According to UNAIDS, Malawi has an HIV prevalence rate of more than 14 percent, and its estimated that almost 1 million people in Malawi are living with HIV/AIDS. One in four HIV-infected children die before the age of 5 -- one of the highest death rates in the world. With more than 65 percent of the population living in poverty, the country has very limited resources to fight the disease.
Malawi currently does not have the capabilities to manage the growing number of HIV-infected children in our existing pediatric clinic in Lilongwe, said Peter N. Kazembe, MD, future director of the new clinic in Malawi. We look forward to a successful working relationship with Baylor and the Abbott Fund to help us more fully address the needs of this vulnerable population.
In addition to the centers in Malawi and Romania supported by the Abbott Fund, Baylor operates centers in Botswana and Uganda with other donors. New clinics in Lesotho and Swaziland will be opened by December 2005. Baylor also is working with health professionals in Libya to enhance the care and treatment of HIV-infected children in Benghazi.
Pediatric HIV treatment in the developing world is a relatively new field, and Baylors approach has proven to be successful, said Jeff Richardson, executive director of the Abbott Funds Step Forward program. Abbott continues to support the Baylor programs to help make an enduring impact in advancing the care of children with HIV/AIDS.
Source: Abbott
Second Strain of Bird Flu Found in US Dairy Cows: What It Means for Infection Prevention and Control
February 7th 2025A new H5N1 strain was found in Nevada dairy cows, challenging earlier transmission theories. This raises concerns about animal vulnerability, human health risks, and food safety. Experts emphasize the need for improved surveillance, biosecurity, and cross-sector collaboration to contain the virus spread.
Fungal Infections: The Silent Epidemic Threatening Global Health
February 6th 2025Fungal infections are a rising global threat, with antifungal resistance complicating treatment. Neil J. Clancy, MD, emphasizes the urgent need for research, better diagnostics, and stronger infection prevention strategies.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
Clean Hospitals With Alexandra Peters, PhD: The Double-Edged Sword of High-Tech
January 30th 2025Despite revolutionary advancements like alcohol-based hand rubs, infection prevention still faces major hurdles. Poor adherence to hygiene, overreliance on technology, and understaffed environmental services create perfect storm conditions for deadly outbreaks.